Holen Sie sich die Stockscreener-App
0.45
0.20%
-0.0009
Vorhandelsmarkt:
.47
0.02
+4.44%
Schlusskurs vom Vortag:
$0.4509
Offen:
$0.45
24-Stunden-Volumen:
1.17M
Relative Volume:
0.10
Marktkapitalisierung:
$19.90M
Einnahmen:
$106.79M
Nettoeinkommen (Verlust:
$-8.73M
KGV:
-2.25
EPS:
-0.2
Netto-Cashflow:
$10.81M
1W Leistung:
+4.51%
1M Leistung:
-15.37%
6M Leistung:
-76.92%
1J Leistung:
-85.39%
1-Tages-Spanne:
$0.4441
$0.495
1-Wochen-Bereich:
$0.3859
$0.495
52-Wochen-Spanne:
$0.2813
$3.445
Harvard Bioscience Inc Stock (HBIO) Company Profile
Firmenname
Harvard Bioscience Inc
Sektor
Telefon
(508) 893-8999
Adresse
84 OCTOBER HILL RD, HOLLISTON, MA
Vergleichen Sie HBIO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HBIO
Harvard Bioscience Inc
|
0.45 | 19.04M | 106.79M | -8.73M | 10.81M | -0.20 |
|
ISRG
Intuitive Surgical Inc
|
516.12 | 185.10B | 8.71B | 2.48B | 1.75B | 6.82 |
|
BDX
Becton Dickinson Co
|
175.33 | 50.76B | 20.87B | 1.50B | 2.59B | 5.24 |
|
ALC
Alcon Inc
|
87.16 | 43.19B | 9.93B | 1.12B | 1.58B | 2.25 |
|
RMD
Resmed Inc
|
261.07 | 37.26B | 5.02B | 1.31B | 1.56B | 8.91 |
|
WST
West Pharmaceutical Services Inc
|
210.08 | 16.13B | 2.90B | 467.20M | 306.90M | 6.37 |
Harvard Bioscience Inc Stock (HBIO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-09 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-03-10 | Hochstufung | The Benchmark Company | Speculative Buy → Buy |
| 2021-01-07 | Hochstufung | The Benchmark Company | Speculative Buy → Buy |
| 2020-12-09 | Eingeleitet | Northland Capital | Outperform |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2019-07-08 | Herabstufung | Janney | Buy → Neutral |
| 2018-01-24 | Bestätigt | Janney | Buy |
| 2018-01-23 | Bestätigt | The Benchmark Company | Buy |
| 2016-11-17 | Eingeleitet | Singular Research | Buy |
| 2015-07-28 | Eingeleitet | The Benchmark Company | Buy |
Alle ansehen
Harvard Bioscience Inc Aktie (HBIO) Neueste Nachrichten
What drives Harvard Bioscience Inc. stock priceOutperformance with explosive growth - jammulinksnews.com
Is Harvard Bioscience Inc. a good long term investmentExceptional gains - jammulinksnews.com
What analysts say about Harvard Bioscience Inc. stockDouble-digit growth - jammulinksnews.com
Harvard Bioscience announces CEO succession plan - MSN
Harvard Bioscience Inc. Stock Analysis and ForecastFree Stock Index Interpretation - jammulinksnews.com
Harvard Bioscience stock holds Speculative Buy rating at Benchmark - Investing.com India
Harvard Bioscience Announces CEO Succession Plan & Appointment of Two New Independent Directors to Board - GlobeNewswire
Harvard Bioscience Announces CEO Succession Plan - TipRanks
Harvard Bioscience names John Duke as new CEO as Jim Green retires By Investing.com - Investing.com South Africa
Harvard Bioscience names John Duke as new CEO as Jim Green retires - Investing.com
Harvard Bioscience Taps Growth Expert as New CEO: Former Corning Executive Brings 20% Annual Growth Record - Stock Titan
How Harvard Bioscience Inc. stock performs during market volatilitySafe and Scalable Investment Tips - Newser
Why Harvard Bioscience Inc. stock attracts strong analyst attentionDaily Breakout Picks - Newser
What makes Harvard Bioscience Inc. stock price move sharplyBreakout Confirmation Tool - Newser
Harvard Bioscience (NASDAQ:HBIO) versus Electronic Sensor Technologies (OTCMKTS:ESNR) Financial Comparison - Defense World
Is Harvard Bioscience, Inc. technically bullish or bearish? - MarketsMojo
Harvard Bioscience falls out of Nasdaq compliance after board member resignation - Worcester Business Journal
Harvard Bioscience Faces Nasdaq Compliance Challenge - TipRanks
Financial Fitness Check: Examining Harvard Bioscience Inc (HBIO)’s Key Ratios - DWinneX
Major Improvements In Harvard Bioscience Inc (HBIO) Stock Need To Be Considered - Stocksregister
Harvard Bioscience appoints new board member as director steps down - Worcester Business Journal
What Did We Find About Insider Trading At Harvard Bioscience Inc (NASDAQ: HBIO)? - Stocksregister
Harvard Bioscience Appoints John Duke to Board of Directors - The Manila Times
Harvard Bioscience appoints new board member By Investing.com - Investing.com South Africa
Harvard Bioscience Approves Incentive Plan Amendment - TipRanks
Harvard Bioscience appoints new board member - Investing.com
Harvard Bioscience Appoints John Duke to Board of Directors | HB - GuruFocus
Harvard Bioscience Strengthens Board with Ex-Corning Life Sciences Leader John Duke, Names New Lead Director - Stock Titan
Little Excitement Around Harvard Bioscience, Inc.'s (NASDAQ:HBIO) Revenues As Shares Take 26% Pounding - simplywall.st
Harvard Bioscience First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
Harvard Bioscience price target lowered to $3 from $4.50 at Benchmark - Yahoo Finance
Harvard Bioscience outlines Q2 revenue target of $18M–$20M amid product launches and cost actions - MSN
Finanzdaten der Harvard Bioscience Inc-Aktie (HBIO)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.28%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):